Fig. 1
Study Design. Abbreviations: ADA, anti-drug antibody; DRL_RI, biosimilar rituximab; N, total number of patients; n, number of patients in each treatment group; RA, rheumatoid arthritis
Fig. 1 | Arthritis Research & Therapy
Study Design. Abbreviations: ADA, anti-drug antibody; DRL_RI, biosimilar rituximab; N, total number of patients; n, number of patients in each treatment group; RA, rheumatoid arthritis